IVC Industries sales jump 16.9% in FY 1996; net income down by half due to merger charges.
This article was originally published in The Tan Sheet
Executive Summary
IVC INDUSTRIES SALES JUMP 16.9% TO $104.2 MIL. IN FY 1996 for the 12 months ended July 31. Net income was down by half to $296,000 from $593,000 in the previous 12 months. Net earnings in FY 1996 contain a $3.2 mil. charge to earnings after taxes related to the merger and integration of Hall Labs, the Freehold, N.J.-based vitamins and nutritional supplements manufacturer and marketer noted
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.